What is the recommended management for perisplenic varices associated with portal hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Perisplenic Varices in Portal Hypertension

Perisplenic varices associated with portal hypertension should be managed based on whether they are actively bleeding, with treatment decisions guided by cross-sectional imaging to determine vascular anatomy and the presence of portosystemic shunts, followed by multidisciplinary discussion between gastroenterology/hepatology and interventional radiology to select definitive therapy.

Initial Assessment and Imaging

When perisplenic varices are identified in the context of portal hypertension, obtain contrast-enhanced CT or MRI with portal venous phase imaging to map the complete vascular anatomy 1. This imaging is critical to identify:

  • Presence and size of gastrorenal shunts
  • Splenic vein patency versus occlusion
  • Portal vein patency
  • Inflow sources to the varices
  • Other portosystemic collaterals

The vascular anatomy determines which treatment options are technically feasible and most appropriate 1, 2.

Management Based on Clinical Presentation

Non-Bleeding Perisplenic Varices

For incidentally discovered perisplenic varices without bleeding history:

  • No specific prophylactic intervention is recommended solely for perisplenic varices 1
  • Focus on managing underlying portal hypertension with non-selective beta-blockers if clinically significant portal hypertension is present
  • Monitor for development of gastric or esophageal varices that may require prophylaxis

Bleeding Perisplenic Varices

If perisplenic varices are bleeding or associated with bleeding gastric varices:

Initial stabilization follows standard portal hypertensive bleeding protocols 1:

  • Vasoactive drugs (octreotide or terlipressin)
  • Antibiotic prophylaxis
  • Restrictive transfusion strategy
  • Endoscopic evaluation to identify bleeding source

Definitive treatment selection depends on vascular anatomy 1, 2:

If Gastrorenal Shunt is Present:

  • BRTO (balloon-occluded retrograde transvenous obliteration) is optimal when local expertise exists and severe comorbid portal hypertension complications are absent 1
  • Perform short-interval (48-hour) endoscopy post-BRTO to confirm vascular flow obliteration 1
  • Add cyanoacrylate injection if residual flow detected 1
  • Important caveat: BRTO increases portal pressure and may worsen esophageal varices, requiring surveillance endoscopy 1, 2

If No Suitable Gastrorenal Shunt or Significant Portal Hypertension Complications:

  • TIPS placement with endovascular sclerosis/embolization of varices when feasible 1, 2
  • TIPS addresses underlying portal hypertension and reduces rebleeding risk
  • Covered stents are standard of practice 2

If Splenic Vein Occlusion is Present:

This represents a distinct entity (sinistral/left-sided portal hypertension) requiring different management 2:

  • Partial splenic embolization is highly effective (100% success in controlling bleeding) 2
  • Splenectomy is definitive treatment (100% success, no rebleeding) 2
  • Splenic vein recanalization with angioplasty/stenting addresses the underlying cause 2
  • Endoscopic therapy has poor success (only 40% hemostasis rate) and carries risk of exsanguination 2

Post-Treatment Surveillance

After successful treatment:

  • Cross-sectional imaging at 4-6 weeks to confirm variceal obliteration and assess for vascular complications 1
  • Endoscopic surveillance for esophageal varices, particularly after BRTO which increases portal pressure 1, 2
  • Continue non-selective beta-blockers for portal hypertension management

Critical Decision Points

The key algorithmic approach is:

  1. Obtain vascular imaging first - this determines all subsequent treatment options
  2. Assess for splenic vein occlusion - if present, this fundamentally changes management toward splenic-directed therapy
  3. Identify gastrorenal shunt - if present and patient suitable, BRTO is preferred
  4. Evaluate severity of portal hypertension - high MELD scores or severe complications favor TIPS over BRTO
  5. Consider local expertise - transfer to tertiary center if complex vascular anatomy or specialized procedures needed 1

Common pitfall: Treating perisplenic varices without imaging assessment of vascular anatomy leads to inappropriate therapy selection and treatment failure. Always obtain cross-sectional imaging before definitive intervention 1, 2.

References

Guideline

acr appropriateness criteria® radiologic management of gastric varices.

Journal of the American College of Radiology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.